The China Post
Date: July 26, 2016
By: Ricardo Alonso-Zaldivar ,AP
WASHINGTON — A safeguard for Medicare beneficiaries has become a way for drugmakers to
After 20-year run, Yahoo to sell core business to Verizon for US$4.8 billion In this June 14, 2011 file photo, various prescription drugs are pictured on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, New Jersey. A safeguard for Medicare beneficiaries has become a way for drugmakers to get paid billions of dollars for pricey medications at taxpayer expense, government numbers show. (AP)
get paid billions of dollars for pricey medications at taxpayer expense, government numbers show.
The cost of Medicare’s “catastrophic” prescription coverage jumped by 85 percent in three years, from US$27.7 billion in 2013 to US$51.3 billion in 2015, according to the program’s number-crunching Office of the Actuary.
Out of some 2,750 drugs covered by Medicare’s Part D benefit, two pills for hepatitis C infection — Harvoni and Sovaldi — accounted for nearly US$7.5 billion in catastrophic drug costs in 2015.
The pharmaceutical industry questions the numbers, saying they overstate costs because they don’t factor in manufacturer rebates. However, rebates are not publicly disclosed. Senator Charles Grassley is calling the rise in spending “alarming.”
Medicare’s catastrophic coverage was originally designed to protect seniors with multiple chronic conditions from the cumulatively high costs of taking many different pills. Beneficiaries pay 5 percent after they have spent US$4,850 of their own money. With some drugs now costing more than US$1,000 per pill, that threshold can be crossed quickly. [FULL STORY]